Swedish Cancer Institute

Cary, North Carolina 27513

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Multiple Myeloma Clinical Trial
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Swedish Cancer Institute
mi
from
Cary, NC
Click here to add this to my saved trials